3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
38
Stomach Neoplasms
24
Rectal Neoplasms
19
Pancreatic Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
14
Colonic Neoplasms
14
Esophageal Neoplasms
12
Adenocarcinoma Of Esophagus
12
Carcinoma, Non-Small-Cell Lung
10
Neoplasms
9
Neoplasm Metastasis
9
Adenocarcinoma
9
Cholangiocarcinoma
8
Biliary Tract Neoplasms
6
Ovarian Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Hepatocellular
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Carcinoma
3
Bile Duct Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Recurrence
2
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Oxaliplatin
×
90 days
×
Clear all
No trials found.